Core Laboratories Gains as 4Q View Looks Insulated from Tariffs

Dow Jones
2025/10/24
 

By Katherine Hamilton

 

Core Laboratories shares climbed after the energy-services company gave strong fourth-quarter guidance and said new tariff measures likely won't apply to most of its revenue sources.

The stock jumped 28%, to $16.36, on Thursday. Shares are still down 7% this year.

The company said it expects fourth-quarter revenue to be $132 million to $136 million, which would be ahead of the $128.6 million analysts were projecting, according to FactSet. Earnings per share are guided to be 18 cents to 22 cents, while analysts were forecasting 19 cents.

Core Laboratories believes the tariffs under consideration won't apply to the vast majority of its service revenue and product sales, it said. Services account for more than 75% of the Houston company's total revenue and currently aren't subject to tariffs.

Product sales have made up less than a quarter of total revenue and are primarily manufactured in the U.S. Tariffs on exported goods wouldn't apply to about half of those product sales, as they are consumed in the U.S. drilling and completion markets.

While tariff headwinds are contributing to market volatility and lower commodity prices right now, longer-term crude oil demand remains intact despite tariffs, the company said.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

October 23, 2025 12:18 ET (16:18 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10